drugset / Trial / NCT02227290

Pediatric Subjects With Tinea Corporis

NCT02227290

Phase 4 Completed 230 enrolled Merz North America, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The study is being done to see how well the study cream works when applied once a day to affected area of child (where they have ringworm). The results will be compared to those seen with a placebo cream which has no active ingredient. Safety of the cream will also be measured.

Timeline

Start
2014-08
Primary completion
2015-11
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Naftifine Other / unclassified 2 % Topical

Indications